National Institute of Neurological Disorders and Stroke Accessible version - If you are using special technology To Access the Internet, follow this link Accessible version
NINDS Home page About NINDS NINDS Disorder Information NINDS Funding Information NINDS News And Events NINDS Find People section NINDS Jobs and Training
image For format - no content
 

NINDS logo

   
Science for the Brain The nation's leading supporter of biomedical research on disorders of the brain and nervous system
       
Browse all disorders
       
  Browse all health
   organizations
   
       
  More about
Reflex Sympathetic Dystrophy Syndrome
   
Studies with patients
Research literature
Press releases
       
Disclaimer
 

Search NINDS...
(help)
 
  
  Contact us   
  My privacy

NINDS is part of the
National Institutes of
Health

   
     
NINDS Reflex Sympathetic Dystrophy Syndrome Information Page
Synonym(s):  Chronic Regional Pain Syndrome, Causalgia
Reviewed  02-01-2001  

Get Web page suited for printing
Email this to a friend or colleague


Table of Contents (click to jump to sections)

What is Reflex Sympathetic Dystrophy Syndrome?
Is there any treatment?
What is the prognosis?
What research is being done?

Organizations
Related NINDS Publications

What is Reflex Sympathetic Dystrophy Syndrome?
Reflex sympathetic dystrophy syndrome (RSDS) is a chronic condition characterized by severe burning pain, pathological changes in bone and skin, excessive sweating, tissue swelling, and extreme sensitivity to touch. The syndrome is a nerve disorder that occurs at the site of an injury (most often to the arms or legs). It occurs especially after injuries from high-velocity impacts such as those from bullets or shrapnel. However, it may occur without apparent injury. One visible sign of RSDS near the site of injury is warm, shiny red skin that later becomes cool and bluish.The pain that patients report is out of proportion to the severity of the injury and gets worse, rather than better, over time. Eventually the joints become stiff from disuse, and the skin, muscles, and bone atrophy. The symptoms of RSDS vary in severity and duration. The cause of RSDS is unknown. The disorder is unique in that it simultaneously affects the nerves, skin, muscles, blood vessels, and bones. RSDS can strike at any age but is more common between the ages of 40 and 60, although the number of RSDS cases among adolescents and young adults is increasing. RSDS is diagnosed primarily through observation of the symptoms. Some physicians use thermography to detect changes in body temperature that are common in RSDS. X-rays may also show changes in the bone.

Is there any treatment?
Physicians use a variety of drugs to treat RSDS. Elevation of the extremity and physical therapy are also used to treat RSDS. Injection of a local anestheticis usually the first step in treatment. TENS (transcutaneous electrical stimulation), a procedure in which brief pulses of electricity are applied to nerve endings under the skin, has helped some patients in relieving chronic pain. In some cases, surgical or chemical sympathectomy -- interruption of the affected portion of the sympathetic nervous system -- is necessary to relieve pain. Surgical sympathectomy involves cutting the nerve or nerves, destroying the pain almost instantly, but surgery may also destroy other sensations as well.

What is the prognosis?
Good progress can be made in treating RSDS if treatment is begun early, ideally within three months of the first symptoms. Early treatment often results in remission. If treatment is delayed, however, the disorder can quickly spread to the entire limb, and changes in bone and muscle may become irreversible. In 50 percent of RSDS cases, pain persists longer than 6months and sometimes for years.

What research is being done?
Investigators are studying new approaches to treat RSDS and intervene more aggressively after traumatic injury to lower the patient's chances of developing the disorder. Scientists are studying how signals of the sympathetic nervous system cause pain in RSDS patients. Using a technique called microneurography, these investigators are able to record and measure neural activity in single nerve fibers of affected patients. By testing various hypotheses, these researchers hope to discover the unique mechanism that causes the spontaneous pain of RSDS, and that discovery may lead to new ways of blocking pain.

 Organizations

American Chronic Pain Association (ACPA)

P.O. Box 850
Rocklin CA 95677-0850
ACPA@pacbell.net
www.theacpa.org
Tel: 916-632-0922
Fax: 916-632-3208

National Chronic Pain Outreach Association (NCPOA)

P.O. Box 274
Millboro VA 24460
ncpoa@cfw.com
Tel: 540-862-9437
Fax: 540-862-9485

Reflex Sympathetic Dystrophy Syndrome Association (RSDSA)

P.O. Box 502
Milford CT 06460
jwbroatch@aol.com
www.rsds.org
Tel: 203-877-3790
Fax: same

RSDHope/ Maine RSDS Patient Advocacy Group

P.O. Box 875
Harrison ME 04040-0875
stonehed@megalink.net
www.rsdhope.org
Tel: 207-583-4589



Related NINDS Publications

  • Reflex Sympathetic Dystrophy Syndrome Fact Sheet
  • Reflex Sympathetic Dystrophy Syndrome (RSDS) fact sheet compiled by the National Institute of Neurological Disorders and Stroke (NINDS).
  • Síndrome de Distrofia Simpática Refleja
  • Information on Sindrome de Distrofia Simpatica Refleja/Spanish-language fact sheet on RSDS compiled by the National Institute of Neurological Disorders and Stroke (NINDS).
  • Chronic Pain
  • Chronic pain information page compiled by NINDS.
  • Chronic Pain: Hope Through Research
  • Chronic pain information booklet compiled by NINDS, the National Institute of Neurological Disorders and Stroke.



    This fact sheet is in the public domain. You may copy it.

    Provided by:
    The National Institute of Neurological Disorders and Stroke
    National Institutes of Health
    Bethesda, MD 20892






    Return to top


    Home | About NINDS | Disorders | Funding | News & Events | Find People | Jobs & Training